Author:
Shirata Masahiro,Ito Isao,Ishida Tadashi,Tachibana Hiromasa,Tanabe Naoya,Konishi Satoshi,Oi Issei,Hamao Nobuyoshi,Nishioka Kensuke,Matsumoto Hisako,Yasutomo Yoshiro,Kadowaki Seizo,Ohnishi Hisashi,Tomioka Hiromi,Nishimura Takashi,Hasegawa Yoshinori,Nakagawa Atsushi,Hirai Toyohiro
Abstract
AbstractThe discriminative power of CURB-65 for mortality in community-acquired pneumonia (CAP) is suspected to decrease with age. However, a useful prognostic prediction model for older patients with CAP has not been established. This study aimed to develop and validate a new scoring system for predicting mortality in older patients with CAP. We recruited two prospective cohorts including patients aged ≥ 65 years and hospitalized with CAP. In the derivation (n = 872) and validation cohorts (n = 1,158), the average age was 82.0 and 80.6 years and the 30-day mortality rate was 7.6% (n = 66) and 7.4% (n = 86), respectively. A new scoring system was developed based on factors associated with 30-day mortality, identified by multivariate analysis in the derivation cohort. This scoring system named CHUBA comprised five variables: confusion, hypoxemia (SpO2 ≤ 90% or PaO2 ≤ 60 mmHg), blood urea nitrogen ≥ 30 mg/dL, bedridden state, and serum albumin level ≤ 3.0 g/dL. With regard to 30-day mortality, the area under the receiver operating characteristic curve for CURB-65 and CHUBA was 0.672 (95% confidence interval, 0.607–0.732) and 0.809 (95% confidence interval, 0.751–0.856; P < 0.001), respectively. The effectiveness of CHUBA was statistically confirmed in the external validation cohort. In conclusion, a simpler novel scoring system, CHUBA, was established for predicting mortality in older patients with CAP.
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Metlay, J. P. et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am. J. Respir. Crit. Care Med. 200, e45–e67 (2019).
2. Cillóniz, C. et al. Impact of age and comorbidity on cause and outcome in community-acquired pneumonia. Chest 144, 999–1007 (2013).
3. Kwok, C. S., Loke, Y. K., Woo, K. & Myint, P. K. Risk prediction models for mortality in community-acquired pneumonia: A systematic review. BioMed. Res. Int. 2013, 504136 (2013).
4. Fine, M. J. et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 336, 243–250 (1997).
5. Lim, W. S. et al. Defining community acquired pneumonia severity on presentation to hospital: An international derivation and validation study. Thorax 58, 377–382 (2003).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献